Whether you need a fully-aligned external solution provider or a complementary team for an ongoing Medical Device Software Development project, The RND Group is here to help.
The RND Group recently implemented a Companion Diagnostice Device that utilizes Next Generation Sequencing (NGS) technology.
The RND Group recently completed a project with an industry-leading genomics company to develop an FDA-regulated Companion Diagnostic Device to aid in the identification of cancer patients who qualify for acceptance into clinical trials. This solution integrates bioinformatics software with NGS technology to provide diagnostic results.
The RND Group recently implemented an Internet of Things (IoT) solution to manage a fleet of medical devices.
The RND Group recently implemented an Internet of Things (IoT) solution to manage a fleet of medical devices that perform diagnostic tests and push raw test data to the cloud. Our solution integrates cloud-based services giving technicians the ability to calculate results from data stored in the cloud by their IoT Devices. The following graphic shows how it …
The RND Group recently completed a project with an industry-leading medical diagnostics company.
The RND Group recently completed a project with an industry-leading medical diagnostics company to assess and remediate a software package for use in FDA-regulated environments. The company filled a portfolio gap through an acquisition of a niche software company in Europe. The acquisition included a large laboratory management software package.
The RND Group recently completed a project to develop a state of the art pharmaceutical compounding system.
The RND Group recently completed a project with an industry-leading medical device company to develop a state of the art pharmaceutical compounding system. The system allows for individualized patient nutritional mixtures to be compounded in a safe, accurate and efficient manner. The system will be marketed to hospital and outsourcing pharmacies.
The RND Group and an industry-leading molecular diagnostics instrument company.
Software in the cloud. The RND Group worked with an industry-leading molecular diagnostics instrument company to provide a cloud-based product. This product needed robust software that could allow the users of the device to perform a multitude of functions to be successful. The software was designed to: Provide users the ability to view and report on de-identified patient test …
The RND Group partners with a privately owned molecular diagnostic equipment manufacturer.
Rheonix, Inc. Rheonix, Inc., is a privately owned molecular diagnostic equipment manufacturer that produces the Encompass family of workstations. The workstations have two initial market-specific deployments – the Encompass MDx® workstation for detection of human disease conditions for the healthcare clinical testing industry and the Encompass Optimum™ workstation for detection of spoilage organisms and pathogens for the food and beverage industry. The workstations are very …
Convergent Dental partners with RND Group to assist with their Solea System dental laser.
Convergent Dental Convergent Dental, Inc., is a privately owned dental equipment and technology company and developer of Solea™, the world’s first computer-aided, CO2 laser system to ever be cleared by the FDA for both hard and soft tissue indications. Solea cuts significantly quieter, finer and faster than any other laser-based system in dentistry. Solea’s speed and precision are a result of …
InstantLabs enlists The RND Group to implement enhancements to their Accelerated-PCR system.
InstantLabs, a molecular diagnostic device company, developed and markets the Hunter Accelerated-PCR system, a fully-integrated, portable and affordable real-time polymerase chain reaction (RT-PCR) platform for rapid, accurate pathogen detection. The company currently offers the Hunter system to use with several foodborne pathogen test kits for the global food industry. The Hunter system is especially well suited for use at …